Please login to the form below

Not currently logged in
Email:
Password:

Zogenix

This page shows the latest Zogenix news and features for those working in and with pharma, biotech and healthcare.

Purdue gets FDA nod for abuse-deterrent painkiller

Purdue gets FDA nod for abuse-deterrent painkiller

The new product will compete in the marketplace against products such as Zogenix' 12-hour Zohydro ER (hydrocodone), another long-acting opioid analgesic which was approved by the FDA last year ... Zogenix filed for approval of a line extension based on

Latest news

  • Dancing with the Deval Dancing with the Deval

    One critic (among many) was Massachusetts state governor Deval Patrick, who announced he was banning Zohydro from his state until its maker Zogenix developed an abuse-deterrent version.

  • FDA releases guidance on how to prevent abuse of opioid painkillers FDA releases guidance on how to prevent abuse of opioid painkillers

    The guidance comes one month after an FDA advisory committee voted against the approval of opioid-containing Zohydro from Zogenix due in part to its potential for abuse. ... Zogenix is currently working on an abuse-deterrent formulation of its drug.

  • Migraine drugs' headache Migraine drugs' headache

    Injectable therapies are invasive and difficult to administer, while other therapies that exist, such as Zogenix's Sumavel DosePro needleless, are considered painful and can result in bruising.

  • Dermatology developments

    Phase II. 130. Durect/Zogenix. Licenses long acting injectable risperidone to combine with Zogenix needle-free system.

  • Next generation

    China . Sumatriptan needle-free injection . Sumavel DosePro (Zogenix, Astellas Pharma). Migraine, cluster headache.

More from news
Approximately 0 fully matching, plus 7 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest appointments

More from appointments
Approximately 1 fully matching, plus 0 partially matching documents found.

Latest from PMHub

  • Mind+Matter Mind+Matter

    Spark Therapeutics, Superdrug, Thornton &Ross, Vetoquinol, VMIC,  Zogenix.

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Havas Life Medicom

We’re a specialist-led, unified communications agency delivering connected healthcare communications, informed through fresh insights, smart thinking and inspired ideas. Our...

Latest intelligence

WHITE PAPER: Why do men die younger?
It’s a commonly accepted fact that women outlive men. Wherever you live, there’s a good chance that men will die on average eight years earlier than women. Is this an...
3 tips to show patient diversity in your clinical trial materials
Here are some useful tips to help get your hands on authentically diverse stock photos....
01 PME-APR21 Cover.jpg
Virtual congresses: video thrilled the cardio tsar
Chris Ross explores the key learnings from a year of virtual congresses...

Infographics